JNCE
Jounce Therapeutics, Inc. Common Stock
JNCE
JNCE
Delisted
JNCE was delisted on the 3rd of May, 2023.
80 hedge funds and large institutions have $153M invested in Jounce Therapeutics, Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 25 increasing their positions, 30 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 13
Holders
80
Holding in Top 10
3
Calls
$171K
Puts
–
Top Buyers
| 1 | +$1.25M | |
| 2 | +$1.24M | |
| 3 | +$1.11M | |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$914K |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$823K |
Top Sellers
| 1 | -$1.64M | |
| 2 | -$999K | |
| 3 | -$962K | |
| 4 |
Millennium Management
New York
|
-$735K |
| 5 |
Morgan Stanley
New York
|
-$500K |